The I-MDx 2025, the 7th Annual Molecular Diagnostics Industry Conference and Exhibition, will be held at a five-star hotel in Nanjing, Jiangsu, China. Hosted by Shanghai Truesaw Business Consulting Co., Ltd., this event focuses on advancements and innovations in the molecular diagnostics industry. Attendees can expect insightful discussions, networking opportunities, and exhibitions showcasing the latest developments in molecular diagnostics.
April 24, 2025 | 15:30-14:00 Beijing Time CST | Location: Oncology Forum
Join us as we explore the transformation of oncology testing from centralized laboratories to decentralized, patient-focused care, driven by groundbreaking diagnostic advancements. Discover how next-generation molecular reagents for qPCR, isothermal amplification, and NGS are paving the way for more accessible and precise oncology diagnostics. Learn how leveraging alternative specimens—such as blood, urine, sputum, and stool—can streamline workflows and ensure assay stability at ambient temperatures, reducing the need for resource-intensive shipping and storage. We’ll showcase how Meridian is at the forefront of these innovations, overcoming traditional barriers and empowering diagnostic developers to accelerate the creation of sustainable solutions.
About The Speaker
Finn previously worked at CDC and QIAGEN, with years of experience in qPCR reagent development and technical support for POCT platforms.
